Literature DB >> 30089305

Inpatient Cost of Stroke in Beijing: A Descriptive Analysis.

Xuejun Yin, Lieyu Huang, Xiaowei Man, Yan Jiang, Xuan Zhao, Liying Zhao, Wei Cheng.   

Abstract

BACKGROUND: Stroke has been the leading cause of death in China and contributed almost one-third to stroke deaths worldwide. The rising cost of stroke treatment is of great concern, but has not been thoroughly studied. This study aimed to analyze stroke in-hospital charges by subtypes, age, and sex and investigate potential factors associated with the cost of per stay.
METHODS: The research was a retrospective observational study based on patients with a primary diagnosis of stroke from 31 hospitals in Beijing. Characteristics of total treatment cost and cost of per stay were analyzed. The potential influences on hospital charges were explored using a stepwise multiple regression model.
RESULTS: A total of 16,111 stroke in-patient admissions were identified among which 8.3% was subarachnoid hemorrhage, 22.4% intracerebral hemorrhage, and 69.1% cerebral infarction. The average length of stay (LoS) was 14.5 (11.9) days. The cost of per stay was USD 4,423.9 (6,684.4) among which the out-of-pocket expenses were USD 1,640.2 (3,118.0). Stroke type, age, medical insurance, treatment results, and hospital level were significantly associated with the cost of stroke (p < 0.001).
CONCLUSION: Hospitalization cost of stroke was substantial. These findings provide health policymakers and healthcare professionals with evidence to help guide future spending.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Hospitalization cost; Retrospective observational study; Stroke

Mesh:

Year:  2018        PMID: 30089305     DOI: 10.1159/000491091

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  5 in total

1.  Medical Service Utilization and Direct Medical Cost of Stroke in Urban China.

Authors:  Dawei Zhu; Xuefeng Shi; Stephen Nicholas; Siyuan Chen; Ruoxi Ding; Lieyu Huang; Yong Ma; Ping He
Journal:  Int J Health Policy Manag       Date:  2022-03-01

2.  The direct and indirect effects of length of hospital stay on the costs of inpatients with stroke in Ningxia, China, between 2015 and 2020: A retrospective study using quantile regression and structural equation models.

Authors:  Ming Su; Dongfeng Pan; Yuan Zhao; Chen Chen; Xingtian Wang; Wenwen Lu; Hua Meng; Xinya Su; Peifeng Liang
Journal:  Front Public Health       Date:  2022-08-12

3.  Hospitalization costs among immobile patients with hemorrhagic or ischemic stroke in China: a multicenter cross-sectional study.

Authors:  Hongpeng Liu; Chen Zhu; Jing Cao; Jing Jiao; Baoyun Song; Jingfen Jin; Yilan Liu; Xianxiu Wen; Shouzhen Cheng; Xinjuan Wu
Journal:  BMC Health Serv Res       Date:  2020-09-29       Impact factor: 2.655

4.  Cost-Effectiveness of Alirocumab for the Secondary Prevention of Cardiovascular Events after Myocardial Infarction in the Chinese Setting.

Authors:  Zhe Liang; Qi Chen; Ruiqi Wei; Chenyao Ma; Xuehui Zhang; Xue Chen; Fang Fang; Quanming Zhao
Journal:  Front Pharmacol       Date:  2021-04-14       Impact factor: 5.810

5.  Societal Cost of Ischemic Stroke in Romania: Results from a Retrospective County-Level Study.

Authors:  Stefan Strilciuc; Diana Alecsandra Grad; Vlad Mixich; Adina Stan; Anca Dana Buzoianu; Cristian Vladescu; Mihaela Adela Vintan
Journal:  Brain Sci       Date:  2021-05-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.